|Bid||2,748.50 x 0|
|Ask||2,749.00 x 0|
|Day's range||2,691.50 - 2,757.00|
|52-week range||2,422.50 - 3,308.50|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||9.86|
|Earnings date||17 Feb 2021|
|Forward dividend & yield||2.16 (8.01%)|
|Ex-dividend date||08 Jul 2021|
|1y target est||3,825.26|
Traders had a muted reaction to news in the UK that unemployment had unexpectedly fallen to 4.9%.
OrganiGram Holdings (NASDAQ: OGI) reported its fiscal second-quarter 2021 results this morning, and the stock initially dropped 12% on the report. The decline quickly eased, however, with shares trading about 2% lower than Monday's close as of 10:20 a.m. EDT. OrganiGram CEO Greg Engel noted the business was "challenged by industry dynamics, COVID-19 and staffing limitations at our facility."
Shareholders of tobacco giant British American Tobacco (NYSE: BTI) had to be happy with the month of March, as shares gained 11.6% in the period, according to data provided by S&P Global Market Intelligence. In mid-February, when the company reported its fiscal 2020 results, BAT updated investors on several aspects of its "new categories" segment. Its Vuse vapor revenue grew 85%, for example.